CIPLA
Back to All Ratios
|
CIPLA Last 5 Year Asset Turnover History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Asset Turnover(x) | 1.08 | 1.16 | 1.11 | 1.15 | 1.17 |
What is the latest Asset Turnover ratio of CIPLA ?
Year | Asset Turnover |
---|---|
Mar2025 | 1.08 |
Mar2024 | 1.16 |
Mar2023 | 1.11 |
Mar2022 | 1.15 |
Mar2021 | 1.17 |
How is Asset Turnover of CIPLA Trending?
Years | Asset Turnover | % Change | |
---|---|---|---|
Mar2025 | 1.08 | -6.90 | |
Mar2024 | 1.16 | 4.50 | |
Mar2023 | 1.11 | -3.48 | |
Mar2022 | 1.15 | -1.71 | |
Mar2021 | 1.17 | - |
Other Financial Ratios of CIPLA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Asset Turnover ratio of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹125,475.6 Cr | -2.2% | 3.6% | -4.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,622.0 Cr | 2% | -2.3% | -12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,536.0 Cr | -1.3% | -6.2% | 21.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,162.0 Cr | -0% | -0.3% | 5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,874.0 Cr | -0.9% | 4.5% | -8.6% | Stock Analytics | |
MANKIND PHARMA | ₹105,315.0 Cr | 1.3% | -2.5% | 7.2% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -2.2% |
3.6% |
-4.5% |
SENSEX | 1.1% |
-0.4% |
-2.2% |
You may also like the below Video Courses